glp-1 colorectal cancer risk study november 2025 GLP-1s in Oncology: Exploring Risks and Potential Benefits Mapping the effectiveness and risks

Zepbound's dual GLP-1/GIP mechanism curbs hunger 47% by day 7, delays gastric emptying, enhances fullness signals to the brain

This blog post will walk you through important safety information when it comes to liraglutide dose adjustments and injections, so you can feel confident and in control every step of the way.

Embarrassed by stomach noises after gastric sleeve

Compared with diabetic patients who did not use GLP-1 RAs having an incidence of 12.85 per 1000 person-years, the adjusted hazard ratio (HR) of DR was 0.42 [95% confidence interval (CI), 0.290.61]

Learn what to watch for and schedule a free consultation.

Heres everything the CPG industry should know to get ahead of the competition.